Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Shares, No Par Value
-
Shares outstanding
-
28.5M
-
Number of holders
-
2
-
Total 13F shares, excl. options
-
826K
-
Shares change
-
-7.87K
-
Total reported value, excl. options
-
$2.05M
-
Value change
-
-$20.4K
-
Number of buys
-
1
-
Number of sells
-
-1
-
Price
-
$2.49
Significant Holders of Oncocyte Corporation - Common Shares, No Par Value (OCX) as of Q4 2023
2 filings reported holding OCX - Oncocyte Corporation - Common Shares, No Par Value as of Q4 2023.
Oncocyte Corporation - Common Shares, No Par Value (OCX) has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 826K shares
of 28.5M outstanding shares and own 2.9% of the company stock.
Largest 2 shareholders include AWM Investment Company, Inc. (754K shares) and Defender Capital, LLC. (71.7K shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.